MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan criteria

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Sato, Fumiaki ^a   Hatano, Etsuro ^a   Kitamura, Koji ^a   Myomoto, Akira ^a,b   Fujiwara, Takeshi ^a   Takizawa, Satoko ^b   Tsuchiya, Soken ^a   Tsujimoto, Gozoh ^a   Uemoto, Shinji ^a   Shimizu, Kazuharu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 96; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION PROFILING; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MILAN CRITERIA; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; SURVIVAL; VALIDATION PROCESS; LIVER TUMOR; MIDDLE AGED; MORTALITY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROGNOSIS; RECURRENT DISEASE; TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; ROC CURVE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79551507191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016435     Document Type: Article

References (35)

1. Stewart B, Kleihues P (2003) World Cancer Report. Lyon: IARC Press.
2. Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, et al. (1998) Hepatocellular carcinoma. Br J Surg 85: 1319-1331.
3. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750.
4. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC (1997) Increase in primary liver cancer in the UK, 1979-94. Lancet 350: 1142-1143.
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699.
6. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, et al. (2000) Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 190: 580-587.
7. Michel J, Suc B, Montpeyroux F, Hachemanne S, Blanc P, et al. (1997) Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 26: 1274-1280.
8. Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, et al. (2007) Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 142: 685-694.
9. Ito T, Takada Y, Ueda M, Haga H, Maetani Y, et al. (2007) Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 13: 1637-1644.
10. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
11. Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: D109-111.
12. Zamore PD, Haley B (2005) Ribo-gnome: the big world of small RNAs. Science 309: 1519-1524.
13. Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22: 165-173.
14. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
15. Tsuchiya S, Okuno Y, Tsujimoto G (2006) MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer. J Pharmacol Sci 101: 267-270.
16. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
17. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
18. Ye QH, Qin LX, Forgues M, He P, Kim JW, et al. (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9: 416-423.
19. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, et al. (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40: 667-676.
20. Iizuka N, Hamamoto Y, Oka M (2004) Predicting individual outcomes in hepatocellular carcinoma. Lancet 364: 1837-1839.
21. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004.
22. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, et al. (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47: 897-907.
23. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
24. Ito T, Tanaka E, Kadowaki T, Kan T, Higashiyama M, et al. (2007) An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification. Oncology 73: 366-375.
25. Sato F, Tsuchiya S, Terasawa K, Tsujimoto G (2009) Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One 4: e5540.
26. Liver Cancer Study Group of Japan a (2000) The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. Tokyo: Kanehara & Co., Ltd.
27. Centeno BA, Enkemann SA, Coppola D, Huntsman S, Bloom G, et al. (2005) Classification of human tumors using gene expression profiles obtained after microarray analysis of fine-needle aspiration biopsy samples. Cancer 105: 101-109.
28. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
29. Utsunomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, et al. (2010) Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol 45: 146-152.
30. Simon F, Bockhorn M, Praha C, Baba HA, Broelsch CE, et al. (2010) Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue-influence of a modulated host stroma on the prognosis of HCC. Langenbecks Arch Surg.
31. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963.
32. Guttilla IK, White BA (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284: 23204-23216.
33. FDA USMicroArray Quality Control MAQC). http://www.fda.gov/ScienceResearch/BioinformaticsTools/MicroarrayQualityControlProject/default.htm.
34. Wang H, Ach RA, Curry B (2007) Direct and sensitive miRNA profiling from low-input total RNA. Rna 13: 151-159.
35. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, et al. (2009) Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 4: e6229.